We may be confronting a perfect storm driven by three primary forces: destructive effects of the Inflation Reduction Act (IRA), legal/regulatory battles over copay adjustment programs, and uncertainties following a national election.
As we approach 2025, it’s crucial for manufacturers to take proactive steps to ensure resilient and responsive patient support programs.
Tune in as we examine the key forces likely to impact patient support programs (PSPs) in the coming year, including the steps manufacturers can take to ride out the storm and offer powerful programs despite these challenges.
In this session, we’ll cover:
Assessing your brand portfolio for specific risks
Leveraging your government affairs for legislative insights
Building strong partnerships with patient advocacy groups
Don’t miss this opportunity to equip yourself with the knowledge and strategies to thrive in a changing landscape. Secure your spot today and be ready to lead in patient support!
In his more than 25-year career, Chris has become a recognized voice in the patient affordability and specialty medication arena, pioneering prominent copay and patient affordability programs, and creating innovative solutions for his clients.
.png?width=240&height=240&name=Dowd%20-%20Chris%202023%20(2).png)
.png?width=320&height=320&name=Dowd%20-%20Chris%202023%20(2).png)